| Dennis Kaighn Constan, PHARMD | |
|
39000 Bob Hope Dr, Rancho Mirage, CA 92270-3221 | |
| (760) 773-1218 | |
| (760) 837-8765 |
| Full Name | Dennis Kaighn Constan |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 39000 Bob Hope Dr, Rancho Mirage, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447018320 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 58115 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dennis Kaighn Constan, PHARMD 2542 Isabella Way, Palm Springs, CA 92262-2372 Ph: (267) 226-3143 | Dennis Kaighn Constan, PHARMD 39000 Bob Hope Dr, Rancho Mirage, CA 92270-3221 Ph: (760) 773-1218 |
News Archive
Fashion retailers have seen an increase in demand for maternity wear in recent years, as sales for maternity clothing have increased while overall women's apparel sales have declined. Currently, most retailers produce maternity wear using a standardized size chart that begins with women in their seventh month of pregnancy. Retailers produce garments for women who are earlier in their terms by adjusting the sizes smaller proportionally based on the standardized chart.
Boehringer Ingelheim and Eli Lilly and Company today presented the full results of the long-term cardiovascular outcome trial, CARMELINA®, which studied the impact of Trajenta® (linagliptin) on cardiovascular and kidney safety in adults with type 2 diabetes at high risk for heart and/or kidney disease.
A new study from the group of Holger Gerhardt in collaboration with Katie Bentley's Lab addresses a long standing question in the wider field of developmental biology and tissue patterning in general, and in the vascular biology field in particular: 'What are the fundamental mechanisms controlling size and shape of tubular organ systems'.
Boston Therapeutics, Inc., a public company registered with the SEC and a developer of diabetes therapeutics, announced today the initiation of its first clinical trial to evaluate the Safety and Efficacy of PAZ320 when added to oral agents or Insulin regimen in Patients with Type 2 Diabetes Mellitus.
EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced a strategic collaboration with Brigham and Women's Hospital in Boston, to advance basic and clinical research in multiple sclerosis (MS), with the goal of generating new and innovative discoveries that advance treatment for people living with this condition. The multi-faceted agreement will run for up to 5 years, with the potential to renew the alliance thereafter. Both parties decided not to disclose financial details.
› Verified 8 days ago
Julie Song, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 42520 Bob Hope Dr, Rancho Mirage, CA 92270 Phone: 760-568-5651 | |
Stephanie Rabino, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 42520 Bob Hope Dr, Rancho Mirage, CA 92270 Phone: 760-568-5651 | |
Chorig Khatchadourian, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 42520 Bob Hope Dr, Rancho Mirage, CA 92270 Phone: 760-568-5651 | |
Mr. Joseph Michael Kotansky, R PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 39000 Bob Hope Dr, Suite K-114, Rancho Mirage, CA 92270 Phone: 760-773-1219 Fax: 760-773-4289 | |
Han Na Kim, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 42520 Bob Hope Dr, Rancho Mirage, CA 92270 Phone: 760-568-5651 | |
Jason Hindman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 55 Calle De Oro, Rancho Mirage, CA 92270 Phone: 720-838-7825 | |
Mr. David Goldberg, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 36101 Bob Hope Dr, Rancho Mirage, CA 92270 Phone: 760-328-2506 Fax: 760-202-3817 |